The deficiency of dystrophin, a sarcolemmal associated protein, is responsible for Duchenne muscular dys trophy (DMD). Gene replacement is attractive as a potential therapy. In this article, we describe a new method for myoblast transplantation and expression of dystrophin in skeletal muscle tissue of dystrophindeficient mdx mouse through iliac vessels extracorporeal circulation. We evaluated the extracorporeal circu lation as an alternative route of delivering myoblasts to the target tissue. Two series of experiments were performed with the extracorporeal circulation. In a first series, L6 rat myoblasts, transfected with LacZ reporter gene, were perfused in limbs of 15 rats. In the second series, the muscle limbs of three 6-8-weekold mdx were perfused with myoblasts of donor C57BL10J mice. Before these perfusions, the right tibialis anterior (TA) muscle of the rats and mdx was injected three times at several sites with bupivacaine (BPVC) and hyaluronidase. The ability of injected cells to migrate in the host tissue was assessed in rats by technetium-99m cell labeling. No radioactivity was detected in the lungs, bowels, and liver of animals treated with extracorporeal circulation. The tissue integration and viability of the myoblasts were ultimately confirmed by genetic and histochemical analysis of LacZ reporter gene. Following a single extracorporeal perfusion of myoblasts from donor C57BL10J, sarcolemmal expression of dystrophin was observed in clusters of myofib ers in tibialis anterior muscles previously treated with BPVC and hyaluronidase. Furthermore, large clusters of dystrophin-positive fibers were observed in muscles up to 21 days after repeated treatments. These clusters represented an average of 4.2% of the total muscle fibers. These results demonstrate that the extracorporeal circulation allows selective myoblast-mediated gene transfer to muscles, opening new perspectives in muscu lar dystrophy gene therapy.
INTRODUCTION
Dystrophin is a large protein (427 kDa), localized at the sarcolemma. It shares similarities with the cytoskeletal proteins alpha-actinin and spectrin, and is required to anchor integral membrane proteins, such as dystrophin associated glycoproteins (DAGs) (12) . The lack of dys trophin causes Duchenne muscular dystrophy (DMD), a progressive muscle fiber degenerative disease causing muscle weakness and premature death. Presently there is no treatment for DMD, but gene replacement is attrac tive as a potential therapy. The expression of functional dystrophin into muscle fibers was obtained by myoblastmediated gene transfer. This approach was given credi bility by animal studies indicating that injected my oblasts cross the basal lamina and become an integral part of mature host muscle fibers (3) . Clinical trials of donor myoblast transplantation in DMD patients were done. However, a very low number of dystrophin-posi tive fibers was obtained (18, 31) . Intra-aortic myoblast delivery was previously tried by our group in rats and mdx mice (the murine homologue of DMD) to improve the efficiency of implantation of exogenous myoblasts (5, 20) . The result was a uniform distribution in tibialis anterior, extensor digitorum longus, and diaphragm muscles with an average of one positive mature fiber per 1000 fibers, compared to a few around the needle track in direct intramuscular injections. However, the large systemic distribution of injected cells restricted the suc cess of this approach (5) .
In the present study, we describe a new method for myoblast transplantation in mdx through iliac vessels ex-Accepted November 13, 1998. tracorporeal circulation. This approach has the potential for widespread distribution of the gene transfer in the perfused limb through the blood stream. Cell migration in the muscle, and possible diffusion to other organs, was studied by molecular genetic, immunohistochemical analysis, and by technetium-99m (Tc-99m) cell labeling.
MATERIALS AND METHODS

Characterization of Extracorporeal Circulation by
Gammacamera Two series of experiments were performed with the extracorporeal circulation. In the first series of experi ments, we tested the tissue selectivity of extracorporeal circulation with L6 cells labeled with Tc-99m in a limb of five rats. The efficiency of this perfusion was also evaluated with L6 transfected cells, expressing p-galactosidase (}3-gal), in two groups of five rats killed after 2 h and 21 days postperfusion. In the second series, the muscles of a limb of three 6-8-week-old mdx mice were perfused with myoblasts of donor C57BL10J mice.
We tested the tissue selectivity of extracorporeal cir culation with L6 cells labeled with Tc-99m. The radio active ligand was selected by testing many complexes of short-lived Tc-99m (half-time: 6 selection for myoblasts using a differential adhesion method. The mixed myogenic and fibroblastic cell popu lations were incubated for 40 min in culture conditions;
during that time fibrogenic cells adhered to the culture flask, whereas myogenic cells remained in suspension.
The cells derived from muscle were passaged in culture at least six times before their implantation into muscles of mdx/mdx host muscles.
Characterization of Implanted Cells
Immunofluorescence was performed on cell cultures grown onto 24-mm-diameter round coverslips. Cells were washed in PBS, fixed for 15 min in precooled gla cial acetic acid 5%/ethanol 95% at -20°C, washed in PBS and incubated overnight with a rabbit polyclonal anti-desmin 1:40 (DAKO), washed in PBS and than in cubated with the secondary antibody of fluorescein-conjugated rabbit anti-mouse IgG, according to a previously described protocol (7) . Cells were examined under an Axiophot fluorescence microscope (Zeiss).
Myoblast Transplantation
The right tibialis anterior (TA) muscle of animals was chemolysed with five different sites of injections of 2 mg/ml bupivacaine (BPVC) and 15 IU hyaluronidase, (0.5 ml in rats and 150 yd in mdx) every day for 3 days before the transplantation (10) . Both rats and mice were immunosuppressed with daily IP injections of 2.5 mg/ kg FK506 (Fujisawa Pharmaceutical Co. Ltd, Osaka, Ja pan), from the day before the transplant to the day they were sacrificed. Animals were anesthetized with an IP injection of ketamine (10 mg/kg). Surgical exposure of the right iliac vessels was performed by opening the ab domen and the peritoneal cavity and displacing the bow els. Injections were performed in rats through two 0.28mm-gauge cannulae of polyethylene (Becton Dickinson) caudally inserted into the iliac artery and vein. The use of cannulae in mice was extremely difficult. For this reason extracorporeal circulation was achieved through traction threads surrounding the vessels upstream of the injection sites. Traction was produced by pulling the threads, and injections were performed through two 0.20-mm-gauge needles. Cannulae in rats and needles in mice were connected to a peristaltic pump by heparinated tygon tubes (Ika Labortechnik, Staufen, Germany) giving rise to arterial and venous routes. Cells were de livered to the muscle limbs using the artery route. The ends of tygon tubes were bathed in sterile glucosate heparinated solution in a sterile vacutainer. Venous blood was displaced from the vacutainer that connected artery and venous route and pumped back to the artery route. Extracorporeal circulation of myoblasts was performed by laminar flow (100 u,l/min). Due to the absence of a blood oxygenator, the duration of perfusion was only 180 s in rats and 60 s in mice. A few suture stitches (7.0) were applied in rats along the sites of perfusion after vessel clamping and cannulae removing. The abdo men was then sutured.
Tissue Sectioning and Analysis
In the first series of experiments, two groups of five rats (Wistar male of 300 g) were killed by IP pentobarbi tal administration after 2 h and 21 days posttransplanta tion, respectively. In the second series, mdx mice were killed after 21 days posttransplantation. The TA, gas trocnemius, and extensor digitorum longus (EDL) mus cles were taken from the treated hind limbs. The liver, lungs, and kidneys were also removed. All tissues were frozen in liquid nitrogen-cooled isopentane and sec tioned in transverse serial sections. Ten cross-sectional areas of the muscles of the first series of experiments were examined, each comprising 12-u.m sections for his-tochemical detection of p-gal activity and 10-u_m sec tions for the conventional morphological analysis. LacZpositive myofibers were counted from adjacent H&Estained sections and expressed as percentage of the total fibers. We compared chemolysed TA of treated hindlimb to EDL and gastrocnemius of the same hind limb and to contralateral TA (6) . Sixteen cross-sectional areas of the muscles of the second series of experiments were examined, each comprising 12-|xm sections for immuno histochemical detection of dystrophin with a polyclonal antibody against 60 kDa dystrophin, as previously de scribed (25) .
Quantification of LacZ Staining
The cryostat sections were transferred to gelatincoated glass slides. The sections were then fixed by dip ping the slides in a cold (4°C) solution of 0.25% glutaraldehyde in PBS, pH 7.4, for 15 min, rinsed twice for 5 min in PBS, and stained overnight at 37°C with X-Gal at a concentration of 1 mg/ml in 5 mM K 3 Fe(CN), 5 mM K4Fe(CN), 1 mM MgCl 2 in PBS. The slides were rinsed using PBS and examined microscopically for the presence of P-gal-labeled ("blue") myofibers (8) .
Total RNA Extraction and LacZ Gene Expression
Total RNA was extracted using the RNAzol™ B iso lation kit (Biotecx Laboratories, Inc.) from fragments of frozen right TA muscles obtained from the mice of the first experiment at 21 days after transplantation and from one untreated mouse. Total RNA (1.5-2 u,g) was reverse transcribed into single-strand cDNA using ran dom hexamers and the GeneAmp RNA PCR kit (Perkin Elmer). The primers (5'-GTC GTT TAC AAC GTC GTG ACT-3' and 5'-ATG GGC GCA TCG TAA CCG TGC-3') amplified a 272-bp region of LacZ gene as de scribed (17) . The cDNAs of transplanted and of control mdx mice were used as templates for the polymerase chain reaction (PCR) on a thermal cycler (Perkin Elmer) using 30 pmol of each primer and 2 units of Taq DNA polymerase (Amplitaq, Perkin Elmer) in a final volume of 50 (il. The amplification was performed during 5 min at 94°C for the first cycle, denaturation at 94°C for 30 s, annealing at 56°C for 45 s, extention at 72°C for 45 s for the subsequent 35 cycles, and a final extension at 72°C for 10 min. PCR products were electrophorized on a 3.5% agarose gel (1% agarose, 2.5% NuSeive) and photographed under ultraviolet light after staining with ethidium bromide. Control reactions were performed on cDNAs synthesized without reverse transcriptase; no product was observed, indicating that the amplification was not due to contaminating genomic DNA (data not shown).
DNA Extraction, PCR Amplification, and Quantification of the Dystrophin Gene
Genomic DNA from tissue of control mdx/mdx, C57BL10J mice, and from the right TAs of three differ ent mdx/mdx mice sacrificed 21 days after treatment was isolated by pulverizing frozen tissues under liquid nitro gen, adding 500 u.1 of lysis buffer (10 mM Tris-Cl, 100 mM EDTA, 0.5% SDS, and 1 mg/ml proteinase K). The solution was incubated overnight at 45°C. Genomic DNA was extracted with phenol/chloroform, precipi tated with ETOH in the presence of 150 mM of NaCl, and resuspended in 20 UL of autoclaved H 2 0. DNA se quence analysis of normal and mdx dystrophin gene had revealed a single base substitution in mdx mice when compared to normal animals (29) . The sense PCR primer has been designed in order to introduce a muta tion inducing a new site for the restriction enzyme Maelll in the sequence of the normal dystrophin gene but not in the mutated gene of mdx mice (2) . Amplifica tion of a 200-bp fragment was performed on a DNA thermal cycler (Perkin Elmer) in a total volume of 100 | XL using the primers as described (28 
RESULTS
Early Biodistribution of Labeled L6 Cells In Vivo
L6 viability was evaluated before and after labeling with NOEt Tc-99: the viability was 90-95% before and around 90-92% after labeling, suggesting no significant changes.
The biodistribution of radioactivity between two groups of five animals treated with intra-aortic injection (5) and extracorporeal circulation was compared with gammacamera 2 h after treatment ( Fig. 1 A, B) . The time course showed a progressive increase of Tc-99m at 2 h after injection only in the right hind limb treated with the extracorporeal circulation. No radioactivity was re tained in lungs, bowels, and liver of animals treated with the extracorporeal circulation, whereas it was elevated and inversely correlated with cell viability and accuracy of the surgical procedure in the animals treated with the intra-aortic injection.
Histology of Muscles Treated With Extracorporeal Circulation
Before starting our experiments two groups of three control mice were used to evaluate the histological ef fect of extracorporeal circulation. In the first group chemolysed (i.e., treated with bipuvacaine) and nonchemolysed muscles were examined after single extra corporeal circulation with saline solution. The histology of chemolysed muscles of two examined mice presented few foci of degenerating and regenerating fibers 24 h after single extracorporeal circulation. In fact, a signifi cant number of basophilic myotubes with vescicular myonuclei and numerous myotubes of small diameters with central nuclei were evident. The periphery of this muscle mass contained mature myofibers with periph eral nuclei. Edema and infiltrating macrophages and neutrophils were present in perivascular connective tis sue and around the myofibers. The cell infiltration de creased rapidly and disappeared starting 10 days after injection in one examined mouse. In the normal muscles perfused with saline extracorporeal circulation, the ma jority of fibers were peripherally nucleated and no infil tration was seen at 24 h.
In the second group, chemolysed and nonchemolysed muscles of two mice were examined after repeated ex tracorporeal circulations of the saline solution to evalu ate possible muscle damage. In this group, chemolysed muscles contained areas of active degeneration within muscle fibers and activated macrophages with signifi cant increase of inflammatory cellular infiltrate. After three perfusions every 8 h in a day, the cellular infiltrate was more abundant around and along blood vessels with persisting interstitial edema at 36 h after the first extra corporeal circulation, demonstrating that repeated extra corporeal circulations may alter the endothelial structure into BPVC-treated muscles and allow a cell passage through vessels ( Fig. 2A, C, E) . Only a few infiltrating cells were still present at that time in nonchemolysed muscles. The extracorporeal procedure was then repeated with myoblasts in the rats and mdx of both series of our ex periments. The changes in these animals are similar ex cept for the presence of few infarction areas seen by ATPase technique (data not shown). Cell thrombi oc cluding some small arteries were evident after hematox ylin-eosin analysis of blood vessels in these areas (Fig.  3B ).
Enzymatic and Immunohistochemical Labeling of LacZ-Positive Cells in Rats
Under the conditions described in Materials and Methods, about 15-20% of L6 myogenic transfected cells were P-gal positive. In the first series of experi ments, LacZ-positive myofibers were counted from ad jacent H&E-stained sections and expressed as percent age of the total cryosectioned fibers. Thus, (i-gal percentage reliably reflected the (3-gal activity of the segment of muscle from which the sections were taken. At any considered time point, we compared chemolysed TA of treated hind limb to EDL and gastrocnemius of the same hind limb and to contralateral TA. At 2 h after L6 myoblast perfusion, bipuvicaine-treated TA exhib ited a significant number of muscle fibers undergoing a degeneration-regeneration cycle. LacZ-positive cells were evident in perivascular connective tissue of these animal TAs (Fig. 3A) . At day 21 after extracorporeal procedure, we found clusters of LacZ-positive myofibers (0.2 ± 0.73%, p < 0.05) of normal diameter, peripherally located nuclei, and fibrosis near the bipuvicaine-injected areas of TAs of treated limbs. Fibers of the same section exhibited different levels of LacZ activity, some fibers being more intensely stained than others. Most of the labeling was restricted to the three central regions of muscles where most of the bipuvicaine-associated mus cle regeneration was present. Lungs, liver, kidneys, and TA contralateral muscle did not show any positive cell. X-gal-positive cells were also found in the peripheral connective of the right EDL and gastrocnemius (data not shown).
Figure 2. Cryostat sections of TA chemolysed muscle stained for hematoxylin-eosin after repeated extracorporeal circulations (A, C, E) and single extracorporeal circulation with saline solution (B, D, F). (A, xlOO) and (C, x250) Transverse and longitudinal views of TA muscle of a normal mouse treated with three repeated extracorporeal circulations in 24 h. These muscles contain higher percentage of inflammatory cells in comparison to the TA muscle from animals treated with single extracorporeal circulation (B, xlOO and D, x250). Higher magnification shows muscle fibers surrounded by few infiltrated cells (F, x400), but marked inflammation after repeated perfusions was present (E, x250).
LacZ mRNA Expression
We analyzed the presence of (3-gal mRNA in the right TA muscles of the first experiment 21 days after the perfusion with L6 myoblasts stably transfected with pCMVLacZ and in the right TA muscle of control mice.
Using the extracted total RNA and the combined reverse transcription-PCR (RT-PCR) method, we amplified a specific fragment of 272 bp corresponding to a portion of the coding region of LacZ gene starting from the RNA extracted from the perfused TA muscle (Fig. 4A,   lane 3 ). In the same conditions, no amplification product was observed from RNA extracted from TA muscle of the control mouse (Fig. 4A, lane 2) . The positive control of PCR amplification was performed using as template of the reaction 100 pg of the vector pCMVlacZ (Fig.   4A, lane 4) .
Dystrophin Analysis of Perfused Muscles
Before injection, myogenic primary cultures utilized for perfusions expressed the muscle-specific protein, desmin, in 70-80% of the cells. In the second series of experiments, TA muscles were found to have 800 fibers, and therefore a total of over 10 3 fibers per section was examined for the other muscles. Immunofluorescence examination of control mdx muscles revealed the pres ence of dystrophin in some muscle fibers, previously re ported as revertants ( Fig. 5E) (11) . No cross-reactivity of the antibody was observed with autosomal dystrophin-related protein (i.e., utrophin), as already dem onstrated (21) . Sections from muscles of two mdx treated with a single extracorporeal circulation were se lected and immunostained for dystrophin. The total number of dystrophin-positive fibers in the TA muscle cross sections (chemolysed muscle) was not signifi cantly different from the control mdx muscles (1.2 ± 0.09%).
Muscles of three mdx animals into which normal myoblasts had been perfused after repeated extracorpo real circulations were evaluated in chemolysed and nonchemolysed muscles. On the nonchemolysed muscles of animals treated with repeated circulations, the mean number of dystrophin-positive fibers ranged from 6 to 9.8 fibers/section; the mean for the series was 7.6. In the cross-sectional areas, the percentage of dystrophinpositive fibers ranged from 0.8% to 1.3% with a mean percentage of 0.9 ± 0.08. Chemolysed muscles showed dystrophin-positive muscle fibers, with strong sarcolem mal dystrophin immunostaining, within three adjacent cross-sectional areas from the middle of the three TA muscles (Fig. 5A, C, F) . These fibers were generally grouped in some segments of the whole muscle cross section and the mean number of dystrophin-positive fi bers in each of these segments varied from 93 to 137 (i.e., large clusters of dystrophin-positive fibers). On transverse view of these segments, the percentage of dystrophin-positive fibers varied from 14.2% to 17.6%, giving a mean percentage of 16 ±0.23. However, such high percentage was not found outside of these seg ments. The mean percentage of dystrophin-positive fi bers in the whole muscle cross section was 4.2% (Table  1 ). Both Wilcoxon (p < 0.05) and Student's t (p = 0.001) tests indicated a significant difference between chemo lysed and nonchemolysed perfused muscles.
Dystrophin
Gene Quantification in Perfused Muscles Figure 4B (lanes 1-4) shows the Maelll digestion products of PCR amplifications of genomic DNA mix tures obtained from normal and mdx mouse TA muscles. Note that lane 1 representing 100% mdx DNA has no 25-bp band and lane 4 representing 100% normal DNA has no 50-bp band. For each lane the ratio of the inten sity of the 25-bp band (corresponding to normal dys trophin) to the intensity of the 150-bp band was calcu lated and a standard curve was established using these ratios in relation to the proportion of normal genomic DNA in the mixtures before amplification (2) . We ob served in the PCR products performed on genomic DNA from mdx TA muscles 21 days after myoblast perfusion the presence of a 25-bp band in addition to 150-and 50bp bands (Fig. 4B, lane 2) . Densitometric analysis of the ratio of the intensity of 25-and 150-bp bands shows an average value of 5% of normal dystrophin DNA in mdx chemolysed TA muscle.
DISCUSSION
In myoblast-mediated gene transfer, the full-length dystrophin cDNA can be delivered with its intact regula tory sequences, thereby ensuring that different tran scripts and proteins will be produced at the appropriate time. This approach was stimulated by animal studies demonstrating that injected myoblasts cross basal lamina and become an integral part of mature host muscle fibers (3) . Phase I clinical trials revealed no deleterious effects of myoblast transfer to the muscles of DMD patients, and in some cases detected dystrophin gene expression (18, 31) . The efficacy of direct intramuscular injection of myoblasts was limited by several reasons. The number of injections required to implant normal myoblasts dif fusely into the skeletal musculature is very large, also considering that dystrophin, being a structural protein, has a restricted nuclear domain in mature muscle fibers (14) . Moreover, some muscles, such as the diaphragm, are not accessible to direct injection therapy.
Our study investigates extracorporeal administration of myoblasts as an alternative to myoblast implantation therapy for muscular diseases. The utilization of a peri staltic pump offered the possibility to access the iliac vessels in our animal model and to perform the extracor poreal circulation of myoblasts through tygon tubes (ma terial able to inhibit cellular adhesion).
Tc-99m-Labeled Myoblast Biodistribution
Tc-99m-labeled myoblasts were used to characterize early cell biodistribution. This technique allows to get rapid results after the injection and, in bigger animals, Tc-99m photonic emission (140 Kev) permits optimal gammacamera imaging and noninvasive assessment of the efficacy of repeated cell delivery on the same an imal.
NOEt and other dithiocarbamate complexes of tech netium are strongly and steadily bound by murine myo blasts, being selectively deposited on cell membranes. This bond is maintained after cell lysis and high-speed centrifugation. The reason for this stability is still un clear, although related to NOEt high affinity for the lipoproteic layers of cell membranes (16) . In animals intraaortically injected with labeled cells, we found high ra dioactivity in the liver, possibly representing the seques tration by liver cells (isothiocytes) of circulating frag ments of cell membranes derived from the lysis of labeled L6 cells in which NOEt link is still efficient. When vital labeled cells were injected with extracorpo real circulation, the elective enhancement of the trans plantation efficiency in the limb muscle was more evi dent. These data confirmed that this route may offer the advantage of widespread distribution of myoblasts by a single injection, as opposed to multiple intramuscular injections of the treated limb.
Muscle Degeneration and Inflammation
Previous studies have shown that muscle degenera tion and regeneration (1, 24) caused by injection of the local anesthetic BPVC enhance myoblast-mediated in corporation and expression of a reporter gene in myofib ers in vivo. After three daily injections of drugs, a wider spectrum of changes was present 4 days after the first injection. These ranged from rounded fibers damaged to early myotube formation. The process of degeneration and regeneration appeared to be much more active and advanced near the BPVC-injected areas.
The mdx muscle (6-8 weeks old) already displays a high level of muscle regeneration. The comparison in mdx between pharmacologically treated and untreated muscles demonstrated a higher level of myoblast trans fer in chemolysed muscles. The poor success observed in nonchemolysed mdx muscle suggests that muscle re generation is not the only factor involved in the en hancement of myoblast complementation in chemolysed mdx muscles.
The extracorporeal circulation with saline solution did little to change the histology of chemolysed muscles. However, the degree of inflammation varies if chemo lysed muscles were studied after repeated extracorporeal circulations: in this last case more cellular infiltrates around the myofibers and the vascular bundles were ob served as well as the persistence of edema at 36 h after the first extracorporeal circulation.
Morphological Evaluation After Extracorporeal Circulation
In the present study, normothermia and a constant flow rate were maintained during extracorporeal circula tion. The duration of this extracorporeal circulation was only 60 s to reduce the risk of bleeding and to preserve the blood oxygenation. Single myoblast implantation by a 60-s extracorporeal circulation may induce reversible ischemia. This phenomenon is more evident after re peated treatments. The ischemia increases expression of paracrine mechanisms for mediating angiogenesis and regeneration of ischemic skeletal muscles (32) . Moreover, the influence of different endothelial-derived vasoactive substances such as prostacyclin (15) liberated into damaged muscles results from an alter ation of endothelial structures. These events rapidly lead to invasion of the damaged sites by macrophages, granu locytes, and perfused myoblasts. Repeated extracorpo real circulations may alter the endothelial structures into BPVC-treated muscles, allowing cell passage through vessels. The short period of perfusion is compatible with reconstruction of normal tissue architecture (30) . There fore, the presence of small infarcts detected after cell circulation and the evidence near some small arteries of cell thrombi may suggest a cell migration after occlusion of capillaries. Thrombi may be caused by the same in jected cells or by the stress of wall vessels after extracor poreal circulation. It is also possible that mechanical in jury of repeated injections of BPVC and hyaluronidase induce a blood vessel damage, which likely leads to a better delivery of the injected myoblast in the chemo lysed muscle.
Dystrophin Expression
TA muscles pretreated with BPVC showed a fivefold increase in the number of dystrophin-positive fibers compared to untreated muscles. These data confirm the importance of a regenerative process to allow myoblast fusion and formation in differentiated muscle fibers.
However, it is possible that induction of muscle regener ation can increase the number of dystrophin-positive myofibers in the neighborhood of revertant myofibers.
Following extracorporeal circulations, the greatest dys trophin expression in muscle fiber cross sections was 4.2% and PCR analysis of genomic DNA showed an average value of 5% of normal dystrophin DNA. The fusion of implanted donor cells with host myoblasts or host fibers to form dystrophin-positive fibers following repeated circulations was likely due to the higher diffu sion of myoblasts from the vessels.
The FK506 prevented rejection due to incompatible major histocompatibility complexes (MHCs) in the rat and prevented immune reaction against p-gal in the mice.
CONCLUSIONS
In the first series of experiments, the lower enhance ment of |3-gal activity in treated muscles probably indi cates a low transfection efficiency of L6 cell lines. The presence of mRNA of p-gal in this tissue confirmed the specifity of X-gal stain. Thus, our findings suggest that transfection and selection for 12 days with hygromicin of these cells causes a progressive loss of expression of the reporter gene. This conclusion is supported by the data of other authors indicating a reduced expression of exogenous genes induced by DNA methylation and a different expression of the introduced gene in different cell lines (13) . However, the reduced mitotic capacity of transfected and selected donor primary mouse satellite cells led us to use normal untransfected myoblasts in mdx mouse experiments. No clusters of LacZ-positive cells were found in kidney, liver, and lungs, suggesting an elective biodistribution in treated limbs.
For gene therapy to be useful as a treatment for DMD a way will have to be found to produce gene expression in many muscles. This result could be achieved follow ing administration of muscle cells via extracorporeal route. The use of repeated extracorporeal circulations greatly increases the expression of dystrophin following BPVC treatment. This indicates that the myoblasts mi grating along vessels may fuse with nearby muscle-re generating fibers, permitting dystrophin restoration. The problem with this approach is the limited migration of the myoblasts injected in a nonchemolysed muscle. Time course of inflammation in muscle disease should be adequately studied before any new experiments. The recent discovery of the existence of bone marrow-de rived precursors able to migrate and access damaged muscles from the circulation lends supports to studies of blood stream-mediated delivery of genetically modified myoblasts to target tissue (9) .
